Furthermore, the research findings indicate that incorporating risk variables, such as the dimensions of the tumor, the existence of a mural nodule, and increased levels of tumor biomarkers, such as CA 19-9 and CEA, could potentially assist in informing decisions on monitoring, surgical procedures, or alternative therapies for individuals diagnosed with IPMNs. Here, CEACAM5 is linked to neoplasm.